• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生血管性年龄相关性黄斑变性与中风风险:一项基于人群的 5 年随访研究。

Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study.

机构信息

Department of Ophthalmology, Taipei Medical University, Taipei, Taiwan.

出版信息

Stroke. 2010 Apr;41(4):613-7. doi: 10.1161/STROKEAHA.109.571000. Epub 2010 Feb 11.

DOI:10.1161/STROKEAHA.109.571000
PMID:20150546
Abstract

BACKGROUND AND PURPOSE

Using a nationwide population-based data set from Taiwan, this study investigated the relationship between neovascular age-related macular degeneration (AMD) and the risk of stroke over a 5-year period.

METHOD

The study cohort comprised 209 patients who received treatment for AMD between 1999 and 2001. We randomly selected 1045 subjects matched with the study cohort in terms of age and gender for comparison. Cox proportional hazard regressions were performed to compare the 5-year stroke-free survival rate.

RESULTS

Among the sampled patients, 142 patients (11.3%) had strokes during the 5-year follow-up period, 38 (18.2% of the patients with AMD) from the study cohort and 104 (9.9% of patients in the comparison cohort) from the comparison cohort. After adjusting for the patient's age, gender, monthly income, level of urbanization, and the geographic region of the community in which the patient resided and comorbidities, the hazard ratio for stroke during the follow-up period was 2.01 (P=0.001) times greater for patients with AMD than for patients without AMD. The adjusted hazard ratio for stroke during the follow-up period was 2.21 (P=0.001) times higher for patients with AMD > or = 65 years old compared with the same age group in the comparison cohort. However, no significant difference was observed in the risk of stroke between patients with AMD <65 years of age and comparison patients in the same age group.

CONCLUSION

We conclude that neovascular AMD is associated with a higher risk of stroke for patients with AMD > or = 65 years old.

摘要

背景与目的

本研究利用来自台湾的全国性人口基础数据,调查了 5 年内新生血管性年龄相关性黄斑变性(AMD)与中风风险之间的关系。

方法

研究队列包括 1999 年至 2001 年间接受 AMD 治疗的 209 例患者。我们随机选择了 1045 名与研究队列在年龄和性别方面相匹配的患者作为对照。采用 Cox 比例风险回归比较 5 年无中风生存率。

结果

在抽样患者中,142 例(11.3%)在 5 年随访期间发生中风,其中 38 例(AMD 患者的 18.2%)来自研究队列,104 例(对照队列的 9.9%)来自对照队列。在调整了患者年龄、性别、月收入、城市化水平、患者居住社区的地理位置和合并症后,AMD 患者在随访期间发生中风的风险比为 2.01(P=0.001)倍,高于无 AMD 患者。调整后,AMD 患者年龄≥65 岁的中风风险比对照队列中同年龄组高 2.21 倍(P=0.001)。然而,年龄<65 岁的 AMD 患者与同年龄组的对照患者之间的中风风险无显著差异。

结论

我们的结论是,新生血管性 AMD 与年龄≥65 岁的 AMD 患者中风风险增加相关。

相似文献

1
Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study.新生血管性年龄相关性黄斑变性与中风风险:一项基于人群的 5 年随访研究。
Stroke. 2010 Apr;41(4):613-7. doi: 10.1161/STROKEAHA.109.571000. Epub 2010 Feb 11.
2
Neovascular age-related macular degeneration is associated with cataract surgery.新生血管性年龄相关性黄斑变性与白内障手术有关。
Acta Ophthalmol. 2018 Mar;96(2):e213-e217. doi: 10.1111/aos.13511. Epub 2017 Jul 3.
3
Tuberculosis and the risk of ischemic stroke: a 3-year follow-up study.结核病与缺血性卒中风险:一项为期 3 年的随访研究。
Stroke. 2010 Feb;41(2):244-9. doi: 10.1161/STROKEAHA.109.567735. Epub 2009 Dec 24.
4
Age-Related Macular Degeneration and Risk of Degenerative Dementia among the Elderly in Taiwan: A Population-Based Cohort Study.年龄相关性黄斑变性与台湾老年人退行性痴呆风险的关系:一项基于人群的队列研究。
Ophthalmology. 2015 Nov;122(11):2327-2335.e2. doi: 10.1016/j.ophtha.2015.07.033. Epub 2015 Sep 1.
5
Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients.医疗保险覆盖的新生血管性年龄相关性黄斑变性患者的动脉血栓栓塞事件年发生率。
Ophthalmology. 2007 Dec;114(12):2174-8. doi: 10.1016/j.ophtha.2007.09.017.
6
Risks of newly onset hemorrhagic stroke in patients with neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性患者新发出血性中风的风险
Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1277-1285. doi: 10.1002/pds.4299. Epub 2017 Aug 30.
7
Increased risk of Parkinson disease following a diagnosis of neovascular age-related macular degeneration: a retrospective cohort study.诊断出新生血管性年龄相关性黄斑变性后帕金森病风险增加:一项回顾性队列研究。
Am J Ophthalmol. 2014 Feb;157(2):464-469.e1. doi: 10.1016/j.ajo.2013.09.026. Epub 2013 Sep 29.
8
Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.心血管危险因素与年龄相关性黄斑变性的长期发病率:蓝山眼研究
Ophthalmology. 2007 Jun;114(6):1143-50. doi: 10.1016/j.ophtha.2006.09.033. Epub 2007 Feb 1.
9
Increased risk for stroke in burn patients: a population-based one-year follow-up study.烧伤患者中风风险增加:一项基于人群的一年随访研究。
Burns. 2014 Feb;40(1):54-60. doi: 10.1016/j.burns.2013.05.018. Epub 2013 Jul 5.
10
Neovascular age-related macular degeneration is not associated with coronary heart disease in a Chinese Population: a population-based study.中国人群中新生血管性年龄相关性黄斑变性与冠心病无关:一项基于人群的研究。
Acta Ophthalmol. 2017 Nov;95(7):e587-e591. doi: 10.1111/aos.13204. Epub 2016 Aug 20.

引用本文的文献

1
Age-Related Macular Degeneration With Visual Disability Is Associated With Cardiovascular Disease Risk in the Korean Nationwide Cohort.与伴有视力障碍的年龄相关性黄斑变性相关的心血管疾病风险在韩国全国队列中。
J Am Heart Assoc. 2023 May 2;12(9):e028027. doi: 10.1161/JAHA.122.028027. Epub 2023 Apr 29.
2
Efficacy of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-Related Macular Degeneration and Systemic Cardiovascular Risk Factors.抗血管内皮生长因子治疗在新生血管性年龄相关性黄斑变性及全身心血管危险因素中的疗效
J Clin Med. 2021 Oct 6;10(19):4595. doi: 10.3390/jcm10194595.
3
Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration.
抗血管内皮生长因子治疗与渗出性年龄相关性黄斑变性患者卒中、心肌梗死和死亡风险的相关性。
JAMA Ophthalmol. 2019 May 1;137(5):483-490. doi: 10.1001/jamaophthalmol.2018.6891.
4
Age-related macular degeneration and progression of coronary artery calcium: The Multi-Ethnic Study of Atherosclerosis.年龄相关性黄斑变性与冠状动脉钙进展:动脉粥样硬化的多民族研究。
PLoS One. 2018 Jul 18;13(7):e0201000. doi: 10.1371/journal.pone.0201000. eCollection 2018.
5
Blood coagulation parameters after intravitreal injection of aflibercept in patients with neovascular age-related macular degeneration.玻璃体内注射阿柏西普治疗新生血管性年龄相关性黄斑变性患者后的凝血参数
Int Ophthalmol. 2018 Dec;38(6):2397-2402. doi: 10.1007/s10792-017-0741-x. Epub 2017 Oct 12.
6
Relation between Age-Related Macular Degeneration and Cardiovascular Events and Mortality: A Systematic Review and Meta-Analysis.年龄相关性黄斑变性与心血管事件及死亡率之间的关系:一项系统评价和荟萃分析
Biomed Res Int. 2016;2016:8212063. doi: 10.1155/2016/8212063. Epub 2016 Dec 14.
7
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.年龄相关性黄斑变性(AMD)的流行病学:与心血管疾病表型和脂质因素的关联
Eye Vis (Lond). 2016 Dec 22;3:34. doi: 10.1186/s40662-016-0063-5. eCollection 2016.
8
Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death.引入抗血管内皮生长因子疗法治疗年龄相关性黄斑变性并未增加心肌梗死、中风和死亡风险。
Ophthalmology. 2016 Oct;123(10):2225-31. doi: 10.1016/j.ophtha.2016.06.053. Epub 2016 Aug 11.
9
[Analysis of cardiovascular diseases after the upload phase with intravitreal ranibizumab and bevacizumab in patients with exudative age-related macular degeneration].[玻璃体内注射雷珠单抗和贝伐单抗治疗渗出性年龄相关性黄斑变性患者上传阶段后的心血管疾病分析]
Ophthalmologe. 2016 Jul;113(7):589-95. doi: 10.1007/s00347-015-0214-4.
10
Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis.年龄相关性黄斑变性与新发卒中:一项系统评价和荟萃分析。
PLoS One. 2015 Nov 18;10(11):e0142968. doi: 10.1371/journal.pone.0142968. eCollection 2015.